Company news

Diamyd Medical AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

March 23, 2026

Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial

February 24, 2026

Diamyd Medical receives Notice of Allowance for key retogatein US patent

February 9, 2026

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

December 29, 2025

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.